Closed Loop Medicine Ltd. today announced that it has appointed Konstantinos Vlassis as Chief Technology Officer (CTO).
Unlocking tumor immune evasion: IL1RL1+ Treg cells and CAFs collaborate for immunotherapy resistance
Researchers demonstrated that the crosstalk between IL1RL1+ regulatory T-cells (Treg) and cancer-associated fibroblasts (CAFs) drives the tissue repairing.